| __timestamp | Amneal Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 9216000000 |
| Thursday, January 1, 2015 | 367054000 | 8296000000 |
| Friday, January 1, 2016 | 420770000 | 10044000000 |
| Sunday, January 1, 2017 | 507476000 | 11560000000 |
| Monday, January 1, 2018 | 946588000 | 10558000000 |
| Tuesday, January 1, 2019 | 1273376000 | 9351000000 |
| Wednesday, January 1, 2020 | 1364130000 | 8933000000 |
| Friday, January 1, 2021 | 1324696000 | 8284000000 |
| Saturday, January 1, 2022 | 1427596000 | 7952000000 |
| Sunday, January 1, 2023 | 1573042000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis compares the cost of revenue for Teva Pharmaceutical Industries Limited and Amneal Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Teva's cost of revenue consistently surpassed Amneal's, reflecting its larger scale of operations. In 2017, Teva peaked with a cost of revenue of approximately $11.56 billion, while Amneal's highest was around $1.57 billion in 2023. Despite Teva's higher costs, both companies showed a downward trend in recent years, with Teva's costs decreasing by about 31% from 2017 to 2022. Meanwhile, Amneal's costs increased by nearly 368% from 2014 to 2023, indicating its growth trajectory. This data provides a window into the financial strategies and market positions of these pharmaceutical powerhouses.
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: AbbVie Inc. vs Amneal Pharmaceuticals, Inc.
AstraZeneca PLC vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited's Expenses
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Intra-Cellular Therapies, Inc.'s Expenses
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs HUTCHMED (China) Limited
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Dyne Therapeutics, Inc.
Cost of Revenue Comparison: Neurocrine Biosciences, Inc. vs Amneal Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Insmed Incorporated and Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Cytokinetics, Incorporated vs Amneal Pharmaceuticals, Inc.
Cost Insights: Breaking Down Ionis Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Amneal Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated